Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of Splenic Artery Embolization to Treat Symptomatic Portal

NCT03532750 is registered in ClinicalTrials.gov with University of Minnesota as lead sponsor.

NCT NCT03532750
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03532750 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of Splenic Artery Embolization to Treat Symptomatic Portal
Lead sponsor
University of Minnesota
Phase
Not applicable
Overall status
Withdrawn
Start date
November 1, 2018
Completion date
July 1, 2021
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

portal hypertension